Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs. The U.S. Department of Justice stated that the acquired company paid kickbacks to doctors to prescribe the migraine drug Nurtec ODT.
This settlement addresses allegations of unlawful practices aimed at increasing prescriptions for Nurtec ODT. The payment will impact Pfizer's financial results for the period.
The resolution of these charges removes a legal overhang for Pfizer, though the settlement amount reflects the financial consequences of the alleged kickback scheme.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.